Eli Lilly and Company
Isoquinolin and naphthydrin compounds

Last updated:

Abstract:

The present invention provides a compound of Formula II wherein X is selected from the group consisting of CH and N; Q is selected from the group consisting of CH3 and H; R is selected from the group consisting of and; or a pharmaceutically acceptable salt thereof, compositions, methods to treat liver disease and NASH. ##STR00001##

Status:
Grant
Type:

Utility

Filling date:

21 Feb 2018

Issue date:

14 Sep 2021